TrumpRx Expansion: More Discounts on Prescription Drugs

The White House is poised to announce a significant expansion of the TrumpRx.gov program, bringing more affordable prescription drugs directly to consumers. FOX Business has learned that pharmaceutical giants Amgen and GSK are the latest to join the initiative, offering substantial discounts on a growing list of medications.

Expanding Access to Affordable Medications

This expansion brings the total number of discounted medications available on TrumpRx.gov to 54, offered by six pharmaceutical companies. These discounts are a direct result of President Trump’s push for most-favored-nation pricing and the potential implementation of tariffs. The goal is clear: to lower healthcare costs for Americans.

Significant Savings with Amgen and GSK

• Amgen: Will offer medications with discounts up to 80% off retail price. For example, Amjevita, originally priced at $1,484, will be available for just $299. Significant discounts will also be applied to Aimovig and Repatha (62% off).
• GSK: Will discount Incruse by 55% (available for $159) and offer discounts ranging from 10% to 51% on Arnuity, Relenza, and Anoro.

“GSK and Amgen connecting with TrumpRx.gov to offer prescription drugs directly to consumers at most-favored-nations pricing marks another milestone for President Trump’s affordability push,” stated White House spokesman Kush Desai. He further emphasized that TrumpRx.gov is just the first step, with even greater savings anticipated through the President’s Great Healthcare Plan.

Industry Response and Concerns

The Pharmaceutical Research and Manufacturers of America (PhRMA), representing major drug companies, has expressed concerns. CEO Stephen Ubl argues that government-imposed pricing policies could harm U.S. competitiveness and stifle innovation, potentially increasing reliance on foreign pharmaceutical production. Learn more about PhRMA’s position.

A Look at Prescription Drug Cost Trends

The timing of this expansion is particularly relevant given recent trends in prescription drug costs. According to Bureau of Labor Statistics data, prescription drug costs increased 10.4% from January 2021 to January 2025 under the Biden administration. In contrast, during the Trump administration, prices increased by only 0.2% from January 2015 to February 2026.

As Americans continue to seek ways to manage rising medical expenses, initiatives like TrumpRx.gov offer a potential pathway to greater affordability. Stay informed about the latest developments in healthcare and prescription drug pricing by visiting FOX Business.

Disclaimer: Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved.